Bb Biotech AG BB BIOTECH ORD SHS
Bb Biotech AG BB BIOTECH ORD SHS/ CH0038389992 /
0JYO
|
2024-06-28 12:09:39 PM
|
Chg.
+0.10
|
Volume |
Bid5:40:07 PM |
Ask5:40:07 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
40.35CHF
|
+0.25%
|
300
Turnover: 12,105 |
-Bid Size: - |
-Ask Size: - |
2.22 bill.CHF |
4.99% |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-3.77 CHF |
-42.00% |
| EPS Diluted: |
- CHF |
-42.00% |
| Revenues per Share: |
0.01 CHF |
-57.94% |
| Book Value per Share: |
41.94 CHF |
-13.51% |
| Cash Flow per Share: |
3.94 CHF |
-5.56% |
| Dividend per Share: |
2.00 CHF |
-29.82% |
| Total |
in mill. |
|
| Revenues: |
0.53 CHF |
-57.94% |
| Net Income: |
-206.61 CHF |
-42.26% |
| Operating Cash Flow: |
218.28 CHF |
- |
| Cash and Cash Equivalents: |
0.50 CHF |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
4,191.58 |
4,468.58 |
| P/BV ratio: |
0.96 |
1.02 |
| P/CF Ratio: |
10.18 |
10.85 |
| PEG: |
0.25 |
- |
| Earnings Yield: |
-9.40% |
-8.82% |
| Dividend Yield: |
4.99% |
4.68% |
| Market Capitalization |
|
| Market Capitalization: |
2.22 bill. CHF |
2.37 bill. CHF |
| Free Float Market Cap.: |
- CHF |
- CHF |
| Market Cap. / Employee: |
23.63 mill. CHF |
25.2 mill. CHF |
| Shares Outstanding: |
54.85 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
0.00% |
| Net Profit Margin: |
-38,982.45% |
| Return on Equity: |
-8.89% |
| Return on Assets: |
-7.83% |
Financial Strength
| Liquidity I / Cash Ratio: |
- |
| Liquidity II / Quick Ratio: |
- |
| Liquidity III / Current Ratio: |
- |
| Debt / Equity Ratio: |
13.51% |
| Dynam. Debt / Equity Ratio: |
143.83% |
Efficiency
| Employees: |
94 |
| Personal Expenses / Employee: |
- CHF |
| Revenues / Employee: |
5,638.30 CHF |
| Net Income / Employee: |
-2,197,946.81 CHF |
| Total Assets / Employee: |
28,054,829.79 CHF |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
IFRS |
